Zhang Huaying, Yang Wenjing, Zhou Di, Wang Yining, Zhu Leyi, Jiang Mengdi, Zhang Qiang, Sirajuddin Arlene, Arai Andrew E, Zhao Shihua, Lu Minjie
Department of Magnetic Resonance Imaging, Fuwai Hospital, State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Oxford Centre for Clinical Magnetic Resonance Research, John Radcliffe Hospital, National Institute for Health Research Oxford Biomedical Research Centre, Oxford British Heart Foundation Centre of Research Excellence, University of Oxford, Oxford, United Kingdom.
JACC Cardiovasc Imaging. 2025 Aug 28. doi: 10.1016/j.jcmg.2025.06.017.
Heart failure (HF) is a global health burden. Myocardial fibrosis is a crucial promotor in HF progression which can be characterized noninvasively by cardiac magnetic resonance T1 mapping.
This study aims to systemically evaluate the prognostic value of myocardial T1 mapping and extracellular volume fraction (ECV) covering the entire spectrum of HF through a meta-analysis.
We searched PubMed, Web of Science, and SCOPUS for studies examining the prognostic value of T1 mapping in HF with reduced and preserved ejection fraction. Baseline level, mean difference, and HRs were pooled for meta-analysis. Subgroup analyses were conducted according to HF subtypes and clinical characteristics.
Nineteen studies with 5,384 patients (56.2% male) were included in the analysis. Patients with adverse outcomes (mortality, HF-related event, or composite outcome) had higher native T1 and ECV values than those without (weighted mean difference: 41.17 ms and 4.73%, respectively). Both native T1 and ECV were positively associated with endpoints for the entire HF group (HR of 1% increase in ECV: 1.20 [95% CI: 1.13-1.28]; HR of >1% increase: 1.56 [95% CI: 1.40-1.75]; HR binary: 2.62 [95% CI: 2.07-3.32]; HR of 1-ms increase in native T1: 1.02 [95% CI: 1.01-1.03]; HR of ≥10-ms increase: 1.08 [95% CI: 1.05-1.11]; HR binary: 2.93 [95% CI: 2.03-4.23], all P < 0.05). For subgroup cohorts, native T1 had no significant prognostic value in HF with preserved ejection fraction (P > 0.05). Younger patients with HF with severe cardiac insufficiency (NYHA functional class III-IV), persistently increasing ECV, or negative late enhancement who exhibited abnormal T1 mapping were at higher risk of adverse outcomes.
ECV has consistent prognostic implications across HF spectrum, regardless of HF types, clinical characteristics, and various etiology. Native T1 is less predictive than ECV, particularly in HF with preserved ejection fraction.
心力衰竭(HF)是一项全球性的健康负担。心肌纤维化是HF进展的关键促进因素,可通过心脏磁共振T1映射进行无创性表征。
本研究旨在通过荟萃分析系统评估心肌T1映射和细胞外容积分数(ECV)对涵盖整个HF谱的预后价值。
我们在PubMed、科学网和SCOPUS中检索了研究T1映射对射血分数降低和保留的HF患者预后价值的研究。汇总基线水平、平均差异和风险比(HRs)进行荟萃分析。根据HF亚型和临床特征进行亚组分析。
分析纳入了19项研究,共5384例患者(男性占56.2%)。出现不良结局(死亡率、HF相关事件或复合结局)的患者的固有T1和ECV值高于未出现不良结局的患者(加权平均差异分别为41.17毫秒和4.73%)。对于整个HF组,固有T1和ECV均与终点呈正相关(ECV每增加1%的HR:1.20[95%CI:1.13 - 1.28];增加>1%的HR:1.56[95%CI:1.40 - 1.75];二元HR:2.62[95%CI:2.07 - 3.32];固有T1每增加1毫秒的HR:1.02[95%CI:1.01 - 1.03];增加≥10毫秒的HR:1.08[95%CI:1.05 - 1.11];二元HR:2.93[95%CI:2.03 - 4.23],所有P<0.05)。对于亚组队列,固有T1在射血分数保留的HF中无显著预后价值(P>0.05)。患有严重心功能不全(纽约心脏协会功能分级III - IV级)、ECV持续增加或晚期强化为阴性且T1映射异常的年轻HF患者发生不良结局的风险更高。
无论HF类型、临床特征和病因如何,ECV在整个HF谱中具有一致的预后意义。固有T1的预测性低于ECV,特别是在射血分数保留的HF中。